Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia

Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae

(2016) Pranita D. Tamma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries

(2016) Maria Virginia Villegas et al.   PLoS One

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors

(2015) S. Amit et al.   CLINICAL MICROBIOLOGY AND INFECTION

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)

(2015) KE Goodman et al.   Expert Review of Anti-Infective Therapy

Mortality due toblaKPCKlebsiella pneumoniaebacteraemia

(2015) Yedidah Fraenkel-Wandel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

(2014) George L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival

(2014) Ilker Inanç Balkan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit

(2014) Matthaios Papadimitriou-Olivgeris et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Mermel LA (Clin Infect Dis 2013; 56:123-30)

(2013)   CLINICAL INFECTIOUS DISEASES

The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae

(2013) Pranita D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae

(2013) K. Hussein et al.   JOURNAL OF HOSPITAL INFECTION

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

(2012) Zubair A. Qureshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

(2011) O. Zarkotou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections

(2011) D. Ben-David et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes

(2010) May Nguyen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

AmpC  -Lactamases

(2009) G. A. Jacoby   CLINICAL MICROBIOLOGY REVIEWS

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Optimizing bactericidal exposure for β-lactams using prolonged and continuous infusions in the pediatric population

(2009) Joshua D. Courter et al.   PEDIATRIC BLOOD & CANCER

SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS

(2009) Ji-Young Rhee et al.   SHOCK